Status:
TERMINATED
Lipids Profile in Subclinical Hypothyroidism
Lead Sponsor:
HaEmek Medical Center, Israel
Collaborating Sponsors:
University of Palermo
University of Zurich
Conditions:
Subclinical Hypothyroidism
Eligibility:
All Genders
18-85 years
Brief Summary
Overt hypothyroidism is associated with increased risk for cardiovascular disease (CVD) as indicated by hypertension, hypercholesterolemia, and increased low-density lipoprotein cholesterol (LDL-C) le...
Detailed Description
Overt hypothyroidism is associated with increased risk for cardiovascular disease\[CVD\] as indicated by hypertension, hypercholesterolemia, and increased low-density lipoprotein cholesterol (LDL-C) l...
Eligibility Criteria
Inclusion
- Subjects with subclinical hypothyroidism
Exclusion
- Patients taking L-thyroxin therapy
- Patients with known cardiovascular, cerebral or peripheral atherosclerotic disease.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00962221
Start Date
October 1 2009
End Date
October 1 2012
Last Update
September 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endocrine Institute, Haemek Medical Center
Afula, Israel, 18101